...
首页> 外文期刊>International journal of colorectal disease. >Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer
【24h】

Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer

机译:miR-92a的过表达与大肠癌患者的肿瘤转移和预后不良有关

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objectives: MicroRNAs regulate gene expression at the post-transcriptional level and play important roles in cancer development, progression, and metastasis. The aim of this study was to investigate the expression of miR-92a in colorectal cancer and the normal adjacent mucosa and its potential relevance to clinicopathological characteristics and patient survival. Methods: Surgical specimens of cancer tissue and adjacent normal mucosa were obtained from 82 patients with colorectal carcinomas. The relative expression levels of miR-92a mRNA in the cancer and the normal adjacent mucosa were measured by quantitative real-time reverse transcriptase polymerase chain reaction. We analyzed their correlation with tumor metastasis, clinicopathologic parameters, and clinical outcome. Results: The relative expression levels of miR-92a were significantly higher in colorectal cancer tissues than in the normal adjacent mucosa (p < 0.001), and a high expression of miR-92a correlated with advanced clinical stage (p = 0.025), lymph node metastases (p = 0.015), and distant metastases (p = 0.046). Kaplan-Meier analysis indicated that patients with high miR-92a expression had a poor overall survival (p = 0.001). Moreover, multivariate analysis showed that increased expression of miR-92a was an independent predictor of overall survival. Conclusion: This study revealed that miR-92a overexpression was correlated with specific colorectal cancer biopathologic features, such as TNM stage, lymph node and distant metastases, and poor survival of the patients, indicating that miR-92a may serve as a molecular prognostic marker for colorectal cancer and disease progression.
机译:目的:MicroRNA在转录后水平上调节基因表达,并在癌症的发生,发展和转移中发挥重要作用。这项研究的目的是调查miR-92a在大肠癌和正常邻近粘膜中的表达及其与临床病理特征和患者生存率的潜在关系。方法:从82例大肠癌患者中获取癌组织和癌旁正常黏膜的手术标本。通过定量实时逆转录酶聚合酶链反应测量miR-92a mRNA在癌症和正常邻近粘膜中的相对表达水平。我们分析了它们与肿瘤转移,临床病理参数和临床结局的相关性。结果:miR-92a在大肠癌组织中的相对表达水平显着高于正常邻近粘膜(p <0.001),并且miR-92a的高表达与临床晚期(p = 0.025),淋巴结相关转移(p = 0.015)和远处转移(p = 0.046)。 Kaplan-Meier分析表明,miR-92a高表达的患者总生存期较差(p = 0.001)。此外,多变量分析表明,miR-92a表达的增加是整体存活率的独立预测因子。结论:这项研究表明,miR-92a的过表达与特定的结直肠癌生物病理学特征有关,例如TNM分期,淋巴结和远处转移以及患者的不良生存,表明miR-92a可以作为预后的分子预后标记。大肠癌和疾病进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号